Motion sensors for monitoring physical activity in cystic fibrosis: what is the next step?

Abstract Background: There is some evidence to suggest patients with cystic fibrosis (CF) may be less physically active than their healthy peers, and there is increased interest in how to measure physical activity patterns accurately in CF. Objectives: The purpose of this review is to explore the use of motion sensors and review their clinimetric properties and feasibility in CF, and make some suggestions for their future use. Major findings: A search of the literature identified six key articles that investigated the clinimetric properties (reliability, validity, and responsiveness) of motion sensors in CF. There is little data available with regard to the clinimetric properties of motion sensors in CF. Further research is required to collect data on normal values, variability and a clinically meaningful change in people with CF. Information on feasibility shows that patients find the devices acceptable to wear and that data capture is acceptable. Conclusions: Improving physical activity is important in CF; however, there is currently insufficient evidence to recommend the use of motion sensors as clinical assessment tools or as endpoints in clinical trials of interventions to improve physical activity. Motion sensors should only be used as a research tool where their effectiveness can be evaluated.

[1]  Ariel Hecht,et al.  Methodology for Using Long-Term Accelerometry Monitoring to Describe Daily Activity Patterns in COPD , 2009, COPD.

[2]  K. Janz,et al.  Monitoring Exercise in Children and Adolescents with Cystic Fibrosis: Validation of the CSA Accelerometer , 1995 .

[3]  Thierry Troosters,et al.  Physical activity and hospitalization for exacerbation of COPD. , 2006, Chest.

[4]  H. Selvadurai,et al.  Gender differences in habitual activity in children with cystic fibrosis , 2004, Archives of Disease in Childhood.

[5]  Thierry Troosters,et al.  Physical inactivity in patients with COPD, a controlled multi-center pilot-study. , 2010, Respiratory medicine.

[6]  F. Gottrand,et al.  Changes in lung function in young cystic fibrosis patients between two courses of intravenous antibiotics against Pseudomonas aeruginosa , 2009, Pediatric pulmonology.

[7]  N. T. ten Hacken,et al.  Enhancement of daily physical activity increases physical fitness of outclinic COPD patients: results of an exercise counseling program. , 2009, Patient education and counseling.

[8]  Tiffany J Dwyer,et al.  Evaluation of the SenseWear activity monitor during exercise in cystic fibrosis and in health. , 2009, Respiratory medicine.

[9]  B. Ramsey Outcome measures for development of new therapies in cystic fibrosis: are we making progress and what are the next steps? , 2007, Proceedings of the American Thoracic Society.

[10]  Frank C Sciurba,et al.  Activity Monitoring and Energy Expenditure in COPD Patients: A Validation Study , 2007, COPD.

[11]  Greg D Wells,et al.  Reliability and validity of the habitual activity estimation scale (HAES) in patients with cystic fibrosis , 2008, Pediatric pulmonology.

[12]  N. T. ten Hacken,et al.  The effects of a lifestyle physical activity counseling program with feedback of a pedometer during pulmonary rehabilitation in patients with COPD: a pilot study. , 2006, Patient education and counseling.

[13]  P. Jones,et al.  Evaluation of a movement detector to measure daily activity in patients with chronic lung disease. , 1997, The European respiratory journal.

[14]  T. Barstow,et al.  Spectral and bout detection analysis of physical activity patterns in healthy, prepubertal boys and girls , 1998, American Journal of Human Biology.

[15]  Thierry Troosters,et al.  Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. , 2005, American journal of respiratory and critical care medicine.

[16]  Eric Garshick,et al.  Free-living physical activity in COPD: assessment with accelerometer and activity checklist. , 2009, Journal of rehabilitation research and development.

[17]  M. Decramer,et al.  Are patients with COPD more active after pulmonary rehabilitation? , 2008, Chest.

[18]  R. Gosselink,et al.  Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis , 2009, European Respiratory Journal.

[19]  J. Elborn,et al.  Clinical trials in cystic fibrosis. , 2007, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[20]  J. Garrett,et al.  Comparison of physical activity in adolescents with cystic fibrosis versus age‐matched controls , 2000, Pediatric pulmonology.

[21]  H. Magnussen,et al.  Physical activity in patients with COPD , 2008, European Respiratory Journal.

[22]  A. Almudevar,et al.  Peak oxygen uptake and mortality in children with cystic fibrosis , 2004, Thorax.

[23]  M. Moy,et al.  Accuracy of uniaxial accelerometer in chronic obstructive pulmonary disease. , 2008, Journal of rehabilitation research and development.

[24]  R. Zuwallack,et al.  Using pedometers to monitor walking activity in outcome assessment for pulmonary rehabilitation , 2009, Chronic respiratory disease.

[25]  E. López-Collazo,et al.  Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. , 2009, American journal of respiratory and critical care medicine.

[26]  S. Kelsey,et al.  The prognostic value of exercise testing in patients with cystic fibrosis. , 1992, The New England journal of medicine.

[27]  F. Pitta,et al.  Relationship between pulmonary function and physical activity in daily life in patients with COPD. , 2008, Respiratory medicine.

[28]  H. Hebestreit,et al.  Physical activity is independently related to aerobic capacity in cystic fibrosis , 2006, European Respiratory Journal.

[29]  M. Decramer,et al.  Quantifying physical activity in daily life with questionnaires and motion sensors in COPD , 2006, European Respiratory Journal.

[30]  C. Jolley,et al.  A physiological model of patient-reported breathlessness during daily activities in COPD , 2009, European Respiratory Review.